Skip to main content

Adtalem Global Education Inc.

For the period ended Sep 30, 2025. Filed Oct 30, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Oct 30, 2025

CVSA$113.98+3.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 5. Other Information

On September 10, 2025, Mr. Stephen W. Beard, Adtalem’s Chairman and Chief Executive Officer, terminated a 10b5-1 Preset Diversification Program (the “10b5-1 Plan”), previously adopted with respect to the sale of the Company’s common stock. Mr. Beard’s 10b5-1 Plan was adopted on June 10, 2025 and had an end date of May 29, 2026. The 10b5-

1 Plan provided for the sale of up to 108,000 shares of Adtalem’s common stock. As of the date of the termination, no shares of common stock had been sold under the 10b5-1 Plan’s terms.

On September10, 2025, Mr. Douglas G. Beck, Adtalem’s Senior Vice President, General Counsel, Corporate Secretary and Institutional Support Services, terminated his 10b5-1 Plan, previously adopted with respect to the sale of the Company’s common stock. Mr. Beck’s 10b5-1 Plan was adopted on June 13, 2025 and had an end date of June 13, 2026. The 10b5-1 Plan provided for the sale of up to 15,384 shares of Adtalem’s common stock. As of the date of the termination, no shares of common stock had been sold under the 10b5-1 Plan’s terms.

On September 10, 2025, Mr. Manjunath Gangadharan, Adtalem’s Vice President and Chief Accounting Officer, terminated his 10b5-1 Plan, previously adopted with respect to the sale of the Company’s common stock. Mr. Gangadharan’s 10b5-1 Plan wasadopted on May 29, 2023 and had an end date of June 1, 2026. The 10b5-1 Plan provided for the sale of up to 2,222 shares of Adtalem’s common stock. As of the date of the termination, 1,911 shares of common stock had been sold under the 10b5-1 Plan’s terms.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.